IRIS
DE LUCA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.369
NA - Nord America 11.046
AS - Asia 6.509
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 772
AF - Africa 145
OC - Oceania 6
Totale 31.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.802
RU - Federazione Russa 3.226
IE - Irlanda 2.799
SG - Singapore 1.890
CN - Cina 1.721
DE - Germania 1.532
HK - Hong Kong 1.194
UA - Ucraina 1.116
BR - Brasile 1.076
SE - Svezia 1.030
VN - Vietnam 911
FI - Finlandia 546
FR - Francia 478
IN - India 258
IT - Italia 231
GB - Regno Unito 162
AR - Argentina 137
CA - Canada 129
ID - Indonesia 88
MX - Messico 73
BD - Bangladesh 70
KR - Corea 65
EC - Ecuador 63
CO - Colombia 52
ZA - Sudafrica 51
IR - Iran 50
PL - Polonia 47
NL - Olanda 44
IQ - Iraq 41
PY - Paraguay 41
VE - Venezuela 37
JP - Giappone 33
ES - Italia 32
AT - Austria 28
TR - Turchia 28
PK - Pakistan 26
MA - Marocco 22
CL - Cile 21
BE - Belgio 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 16
PH - Filippine 15
KZ - Kazakistan 13
LT - Lituania 13
TN - Tunisia 13
EU - Europa 12
JM - Giamaica 12
KE - Kenya 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
EG - Egitto 10
PE - Perù 10
UY - Uruguay 10
UZ - Uzbekistan 10
JO - Giordania 9
TH - Thailandia 9
BJ - Benin 8
IL - Israele 7
AZ - Azerbaigian 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
HU - Ungheria 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AU - Australia 3
BB - Barbados 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
CR - Costa Rica 3
GR - Grecia 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
KW - Kuwait 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 30.519
Salva come PNG Salva come JPEG
Città #
Dublin 2.799
Jacksonville 1.918
Hong Kong 1.191
San Jose 1.149
Dearborn 1.051
Singapore 749
Wilmington 701
Council Bluffs 581
Ashburn 577
Moscow 481
Beijing 461
Princeton 383
Lawrence 382
Lauterbourg 342
Ho Chi Minh City 302
San Mateo 261
Chandler 254
Los Angeles 229
Hanoi 178
Ann Arbor 168
Columbus 166
Bremen 165
Andover 163
Buffalo 155
São Paulo 104
Santa Clara 101
New York 89
Dallas 78
Houston 78
Hefei 74
Redondo Beach 70
Düsseldorf 67
Nanjing 66
Seoul 63
Orem 60
Norwalk 57
Guangzhou 51
Woodbridge 51
Kunming 50
Munich 49
Tianjin 47
Haiphong 42
Rio de Janeiro 42
Piemonte 40
Toronto 38
Fairfield 37
Frankfurt am Main 37
Nuremberg 37
Jinan 36
Leawood 36
Da Nang 35
Denver 35
Helsinki 34
Monmouth Junction 33
Warsaw 33
Chennai 32
Hangzhou 31
Johannesburg 29
Mexico City 29
Montreal 29
Tokyo 28
Phoenix 27
Chicago 26
Manchester 26
Seattle 26
Biên Hòa 25
Shanghai 24
Amsterdam 23
Ardabil 22
Atlanta 22
Nanchang 22
Guayaquil 21
Poplar 21
Quito 21
Shenzhen 21
London 20
Stockholm 20
Torino 20
Brussels 18
Boston 17
Belo Horizonte 16
Brno 16
Brooklyn 16
Bắc Ninh 16
Campinas 16
Dong Ket 16
Hebei 16
Hải Dương 16
Jakarta 16
Rome 16
San Francisco 16
Boardman 15
Brasília 15
Curitiba 15
Guarulhos 15
Bexley 14
Can Tho 14
New Delhi 14
Ribeirão Preto 14
Shenyang 14
Totale 17.382
Salva come PNG Salva come JPEG
Nome #
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 151
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 140
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 139
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 138
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 135
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 133
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 132
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 132
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 131
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 130
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 128
PCI techniques 127
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 127
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 127
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 126
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 126
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 125
Apical-sparing Tako-tsubo: A case report 124
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 124
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 123
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 123
ACC/AHA and ESC guidelines 123
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 123
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 123
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 122
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 122
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 121
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 121
Adjuncitve pharmacotherapy: Anticoagulation 120
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 120
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 119
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 119
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 119
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 119
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 119
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 119
An unusual case of ECG ST-segment elevation 118
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 118
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 118
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 117
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 117
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 116
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 116
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 116
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 115
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 115
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 115
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 114
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 114
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 113
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 113
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 113
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 113
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 112
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 112
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 112
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 112
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 112
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 111
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 110
Redefining the success of mechanical reperfusion: ST-segment resolution 110
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 110
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 110
A meta-analytic overview of thrombectomy during primary angioplasty 109
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 109
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 109
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 109
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 109
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 108
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 107
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 106
Pharmacological facilitation in primary angioplasty: myth or reality? 106
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 106
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 106
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 106
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 106
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 105
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 105
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 104
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 104
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 102
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 102
Left ventricular angiography and other angiocardiographic techniques 100
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 100
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 100
Mechanical prevention of distal embolization: Rationale and trial results 99
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 99
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 99
Immature platelet fraction and the extent of coronary artery disease: A single centre study 99
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 99
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 98
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 98
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. 98
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 98
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 98
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 98
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 98
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 97
Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease 97
LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY PREDICTING FUNCTIONAL RECOVERY AFTER CORONARY REVASCULARIZATION 96
Totale 11.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.011 0 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/202611.363 364 374 1.088 1.920 737 819 1.866 1.999 743 788 519 146
2026/20271.051 343 708 0 0 0 0 0 0 0 0 0 0
Totale 31.300